InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,070.55
(
1.20%
)
US TECH 100
17,068.80
(
0.39%
)
Dow Jones
38,503.69
(
0.69%
)
Brent Oil
87.30
(
-0.31%
)
Bitcoin
66,385.29
(
-0.04%
)
Post# of 63
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

INFINITI

Send PM Follow Ignore
Followers 174
Posts 22524
Boards Moderated 0
Alias Born 11/01/2012

INFINITI

Re: None

Wednesday, 06/22/2022 7:41:00 AM

Wednesday, June 22, 2022 7:41:00 AM

Post# of 63

Quotient expects to report reagent business generated product sales of $9.8 million in the fourth quarter of fiscal 2022 and full fiscal year 2022 revenue of $38.5 million. The Company recently secured $1.4 million of orders in the first quarter of fiscal year 2023 for its recently CE Marked Extended Immunohematology (IH) MosaiQ solution. As of March 31, 2022, Quotient had $83.2 million in cash and investments and $8.7 million in restricted cash
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up